The Board of the Association of Cardiovascular Interventions of the Polish Cardiac Society (AISN PTK) publishes annual data from the National PCI Registry (ORPKI) operated by the Jagiellonian University Medical College in Krakow. For the first time the AISN PTK report is based on the new electronic database implemented in Poland on January 1^st^, 2014 and verified independently by data submitted to AISN PTK by individual centers.

In 2014, there were 155 invasive cardiology centers registered in the ORPKI database (an increase by 1 center in comparison to 2013) and 92% of them had 24/7 percutaneous coronary intervention (PCI) duty. For the first time the number of catheterization laboratories (cath labs) in Poland remained stable, and even though there was an increase by 1 in absolute numbers, 2 cath labs ceased to admit patients in 2014. This means that the number of active cath labs per 1 million inhabitants is similar to last year and equals 4. There are 571 certified independent PCI operators in Poland in 2015 with 100% of them having any board certification and 74% in cardiology. Center accreditation issued by AISN PTK was awarded to 104 cath labs.

In comparison to 2013, there was a significant increase in the total number of coronary angiographies. There were 226 713 angiographies in 2014 (an increase by 4.8%) -- [Figure 1](#F0001){ref-type="fig"}. Patients' baseline characteristics and prevalence of risk factors are presented in [Table I](#T0001){ref-type="table"}.
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###### 

Demographics and prevalence of risk factors in patients who underwent coronary angiography in 2014

  Name                          Percent or mean
  ----------------------------- -----------------
  Age                           66.2 ±10.9
  Gender, female                38
  Prior stroke                  3.2
  Prior myocardial infarction   22.7
  Prior PCI                     25
  Prior CABG                    5.8
  Smoking                       17.5
  Arterial hypertension         71.5
  Chronic kidney disease        5.2

PCI -- Percutaneous coronary intervention, CABG -- coronary artery bypass graft.

The reason for performing coronary angiography in Polish patients in 2014 is presented in [Table II](#T0002){ref-type="table"}. In more than half of the cases it was the diagnosis of an acute coronary syndrome.

###### 

Baseline diagnosis in patients who underwent coronary angiography

  Diagnosis         Percent
  ----------------- ---------
  STEMI             12.2
  NSTEMI            13.4
  Unstable angina   29.8
  Stable CAD        39.9
  Other             4.7

STEMI -- ST-elevation myocardial infarction, NSTEMI -- non-ST-elevation myocardial infarction, CAD -- coronary artery disease.

A radial approach is used in as many as 66% of all cases of coronary angiography, which represents a 13% rise since 2013. The right radial artery is predominant when radial access is chosen (87%). Radial access site choice according to baseline diagnosis is presented in [Figure 2](#F0002){ref-type="fig"}.

![Radial approach according to diagnosis](PWKI-11-25699-g002){#F0002}

Common complications of coronary angiography were rare in 2014 and occurred predominantly in myocardial infarction cases. Detailed description and odds of occurrence are presented in [Table III](#T0003){ref-type="table"}.

###### 

Periprocedural complications -- coronary angiography

  Name                              Percent   Occurrence
  --------------------------------- --------- ------------
  Death:                            0.047     1/2130
   In STEMI/NSTEMI                  0.12      1/850
   In stable CAD                    0.04      1/2378
  Stroke                            0.015     1/6528
  Major bleeding from access site   0.051     1/1965
  Cardiac arrest                    0.232     1/431
  Anaphylaxis                       0.045     1/2224

STEMI -- ST-elevation myocardial infarction, NSTEMI -- non-ST-elevation myocardial infarction, CAD -- coronary artery disease.

The total number of PCI procedures was 126 241, which is 5.1% more than in 2013. The change in overall number of PCIs in the last 10 years is presented in [Figure 3](#F0003){ref-type="fig"}.
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Percutaneous coronary interventions performed in acute coronary syndromes accounted for 62% of all PCI cases in 2014 -- details are presented in [Table IV](#T0004){ref-type="table"}. There were 26 678 primary PCIs in a ST-elevation myocardial infarction (STEMI) setting, which is similar to 2013 and translates into 692 primary PCIs per 1 million inhabitants in STEMI in Poland in 2014, which puts us in 4^th^ place in Europe according to the recent paper from the European Heart Journal on implementation of the Stent For Life program and is lower than in 2013.

###### 

Percutaneous coronary intervention in acute coronary syndrome

  Diagnosis   Percent
  ----------- ---------
  STEMI       33
  NSTEMI      28
  UA          39
  All         100

STEMI -- ST-elevation myocardial infarction, NSTEMI -- non-ST-elevation myocardial infarction, UA -- unstable angina.

Drug-eluting stents (DES) during PCI were used in 83.5% of cases which is 16.5% more than in 2013 and is steadily rising since 2008. Bioabsorbable vascular stents (BVS) were implanted in 1.5% of patients (both in acute coronary syndrome (ACS) and in stable angina). In patients with stable angina the prevalence of DES stents was as high as 88% -- see details in [Figure 4](#F0004){ref-type="fig"}. On the other hand, there was a 34% decrease in the use of GP IIb/IIIa blockers in the overall population. In patients with STEMI GP IIb/IIIa were used (elective and bail-out) in only 1/3 of cases. Aspiration thrombectomy was rare (17.8%) in STEMI cases.
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The use of modern antiplatelet agents advised by the ESC guidelines such as ticagrelor and prasugrel was very low in 2014 in Poland and less than 6% in STEMI and non-ST-elevation myocardial infarction (NSTEMI) populations -- for details see [Figures 5](#F0005){ref-type="fig"} and [6](#F0006){ref-type="fig"}.
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Percutaneous coronary intervention complications during PCI were highest (death) in a STEMI setting and are presented in [Table V](#T0005){ref-type="table"}.

###### 

Periprocedural complications -- percutaneous coronary intervention

  Parameter                         Percent   Occurrence
  --------------------------------- --------- ------------
  Death                             0.49      1/204
  STEMI                             1.61      1/62
  NSTEMI                            0.52      1/192
  Stable CAD                        0.12      1/843
  Myocardial infarction             0.12      1/812
  Major bleeding from access site   0.13      1/783
  Cardiac arrest                    0.43      1/234
  Anaphylaxis                       0.13      1/812
  Artery perforation                0.17      1/598
  No reflow                         0.61      1/181

STEMI -- ST-elevation myocardial infarction, NSTEMI -- non-ST-elevation myocardial infarction, CAD -- coronary artery disease.

A noticeable increase in the rate of modern diagnostic procedures other than coronary angiography (e.g. intravascular ultrasound -- IVUS, fractional flow reserve -- FFR, optical coherent tomography -- OCT) was observed in 2014. There were 4019 FFR procedures (increase by 85%), 1884 IVUS examinations (increase by 30%) and 371 OCTs (increase by 89%).

Percutaneous extracardiac procedures were also gathered in the new ORPKI database. In 2014 transcatheter aortic valve implantation (TAVI) was performed in 451 patients, percutaneous left atrial appendage closure in 137 cases and therapeutic hypothermia after sudden cardiac arrest in 115. The numbers of selected non-coronary procedures in 2014 are presented in [Table VI](#T0006){ref-type="table"}.

###### 

The number of selected non-coronary procedures in 2014, performed in cardiac centers for adults in Poland

  Selected procedures           Number, *n*
  ----------------------------- -------------
  PTA below the knee            481
  PTA above the knee            1599
  Carotid artery stenting       662
  Vertebral artery stenting     50
  Renal artery stenting         66
  Subclavian artery stenting    150
  Mitral valvuloplasty          57
  Pulmonary valvuloplasty       50
  BAV                           203
  PFO closure                   339
  ASD closure                   333
  VSD closure                   10
  PDA closure                   76
  LAA closure -- percutaneous   137
  TAVI                          451
  Therapeutic hypothermia       115
  Renal denervation             39
  Myocardial biopsy             740

ASD -- Atrial septal defect, BAV -- baloon aortic valvuloplasty, LAA -- left atrial appendage, PDA -- patent ductus arteriosus, PFO -- patent foramen ovale, PTA -- percutaneous transluminal angioplasty, VSD -- ventricular septal defect.

In summary, there was a significant increase in the overall number of coronary angiographies and PCIs in Poland in 2014. The number of active cath labs in Poland remains stable for the 2^nd^ consecutive year though, which might relate to the fact that the country is now well saturated with interventional cardiology centers. On the other hand, the use of attributes of modern interventional cardiology such as DES and BVS stents is growing as well as more frequent choice of a radial access site by PCI operators even in STEMI patients. One should also note a significant rise in the use of additional imaging or diagnostic tools such as FFR, IVUS and OCTs in Poland in 2014.
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